Altogether, the aberrant expression of SOX2 in pancreatic cancer and lung cancer impacts cellular proliferation, stemness and epithelial-mesenchymal transition of cells thus regulating the formation of cancer stem cells46,47. This evidence concerns the gene SOX2 and lung carcinoma.